Total Payments
$8,908
2024 Payments
$1,747
Companies
42
Transactions
498
Medicare Patients
7,410
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$7,740 (86.9%)
Education$968.03 (10.9%)
Other$200.00 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,740 | 449 | 86.9% |
| Education | $968.03 | 48 | 10.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,187 | 61 | $0 (2024) |
| Vifor Pharma, Inc. | $966.04 | 44 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $832.56 | 52 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $731.61 | 40 | $0 (2024) |
| Relypsa, Inc. | $536.86 | 42 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $536.04 | 30 | $0 (2024) |
| Amgen Inc. | $388.55 | 21 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $359.25 | 16 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $335.55 | 21 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $309.52 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,747 | 92 | AstraZeneca Pharmaceuticals LP ($286.39) |
| 2023 | $1,443 | 78 | AstraZeneca Pharmaceuticals LP ($268.65) |
| 2022 | $1,192 | 70 | AstraZeneca Pharmaceuticals LP ($257.61) |
| 2021 | $1,119 | 52 | Vifor Pharma, Inc. ($329.86) |
| 2020 | $519.96 | 26 | AstraZeneca Pharmaceuticals LP ($156.00) |
| 2019 | $979.28 | 50 | Mallinckrodt Enterprises LLC ($217.84) |
| 2018 | $618.06 | 41 | Keryx Biopharmaceuticals, Inc. ($111.92) |
| 2017 | $1,290 | 89 | Relypsa, Inc. ($360.50) |
All Payment Transactions
498 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Nephrology | ||||||
| 11/08/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $21.77 | General |
| 11/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $23.95 | General |
| Category: NEPHROLOGY | ||||||
| 11/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.93 | General |
| 10/23/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $24.18 | General |
| 10/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Immunology | ||||||
| 09/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Nephrology | ||||||
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 09/10/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 09/09/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Nephrology | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,499 | 5,079 | $745,021 | $286,844 |
| 2022 | 15 | 1,776 | 5,761 | $872,700 | $354,626 |
| 2021 | 16 | 2,051 | 6,145 | $1.0M | $431,962 |
| 2020 | 17 | 2,084 | 5,409 | $1.1M | $385,149 |
Total Patients
7,410
Total Services
22,394
Medicare Billing
$1.5M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 454 | 815 | $179,300 | $65,462 | 36.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 107 | 224 | $119,840 | $59,307 | 49.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 264 | 898 | $137,394 | $53,316 | 38.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 74 | 108 | $46,656 | $23,638 | 50.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 108 | 121 | $50,578 | $15,703 | 31.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 87 | 175 | $38,325 | $15,544 | 40.6% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 36 | 2,214 | $33,210 | $15,525 | 46.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 88 | 201 | $49,848 | $10,730 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $33,150 | $10,438 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 93 | 99 | $32,670 | $9,456 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 23 | $6,578 | $2,810 | 42.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 17 | $10,863 | $2,746 | 25.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 34 | 58 | $1,856 | $798.66 | 43.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Office | 2023 | 11 | 13 | $3,224 | $705.91 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,529 | $665.40 | 43.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 152 | 336 | $179,760 | $90,923 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 485 | 821 | $180,620 | $71,807 | 39.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 300 | 973 | $148,869 | $52,414 | 35.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 99 | 146 | $63,072 | $32,790 | 52.0% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 51 | 2,550 | $38,250 | $18,559 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 143 | 143 | $46,475 | $16,725 | 36.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 101 | 107 | $44,726 | $16,023 | 35.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 139 | 152 | $50,160 | $15,539 | 31.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 102 | 185 | $40,515 | $14,311 | 35.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 94 | 194 | $48,112 | $10,755 | 22.4% |
About Dr. Jonathan Wilkerson, M.D
Dr. Jonathan Wilkerson, M.D is a Nephrology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235326737.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Wilkerson, M.D has received a total of $8,908 in payments from pharmaceutical and medical device companies, with $1,747 received in 2024. These payments were reported across 498 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,740).
As a Medicare-enrolled provider, Wilkerson has provided services to 7,410 Medicare beneficiaries, totaling 22,394 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Paducah, KY
- Active Since 09/28/2007
- Last Updated 10/02/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1235326737
Products in Payments
- Veltassa (Drug) $1,224
- Velphoro (Drug) $731.61
- ACTHAR (Biological) $668.77
- FARXIGA (Drug) $651.55
- RAYALDEE (Drug) $621.28
- LOKELMA (Drug) $496.59
- Auryxia (Drug) $391.79
- Kerendia (Drug) $335.55
- JYNARQUE (Drug) $296.45
- SAMSCA (Drug) $239.59
- Rayaldee (Drug) $211.28
- AURYXIA (Drug) $186.39
- NORTHERA (Drug) $183.39
- ENTRESTO (Drug) $167.44
- JARDIANCE (Drug) $153.42
- Uloric (Drug) $144.09
- TARPEYO (Drug) $140.14
- KRYSTEXXA (Biological) $125.25
- Parsabiv (Biological) $117.15
- Crysvita (Drug) $105.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.